Horizon Kinetics Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Horizon Kinetics Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.57M	Sell	44,552 -154	-0.3%	-$8.84K	0.03%	105
2026 Q1	$2.71M	Sell	44,706 -404	-0.9%	-$23.6K	0.03%	99
2025 Q4	$2.43M	Buy	45,110 +197	+0.4%	+$9.48K	0.03%	100
2025 Q3	$2.03M	Sell	44,913 -16,404	-27%	-$766K	0.02%	116
2025 Q2	$2.84M	Buy	61,317 +1,504	+3%	+$73.8K	0.03%	103
2025 Q1	$3.65M	Sell	59,813 -663	-1%	-$38.6K	0.04%	83
2024 Q4	$3.42M	Buy	60,476 +1,094	+2%	+$61.1K	0.04%	89
2024 Q3	$3.07M	Buy	59,382 +14,364	+32%	+$674K	0.05%	96
2024 Q2	$1.87M	Buy	45,018 +1,530	+4%	+$68.5K	0.03%	112
2024 Q1	$2.36M	Buy	43,488 +952	+2%	+$48.5K	0.04%	91
2023 Q4	$2.18M	Buy	42,536 +155	+0.4%	+$8.14K	0.05%	91
2023 Q3	$2.46M	Sell	42,381 -150	-0.4%	-$9.19K	0.05%	85
2023 Q2	$2.72M	Hold	42,531	–	–	0.06%	86
2023 Q1	$2.95M	Sell	42,531 -4,937	-10%	-$348K	0.06%	76
2022 Q4	$3.42M	Sell	47,468 -333	-0.7%	-$25.1K	0.06%	73
2022 Q3	$3.4M	Buy	47,801 +220	+0.5%	+$16K	0.07%	69
2022 Q2	$3.66M	Sell	47,581 -283	-0.6%	-$21.6K	0.08%	70
2022 Q1	$3.5M	Sell	47,864 -120	-0.3%	-$8.06K	0.07%	84
2021 Q4	$2.99M	Buy	47,984 +975	+2%	+$57.2K	0.07%	95
2021 Q3	$2.78M	Sell	47,009 -700	-1%	-$46.1K	0.07%	98
2021 Q2	$3.19M	Sell	47,709 -12	-0%	-$782	0.06%	95
2021 Q1	$3.01M	Sell	47,721 -20	-0%	-$1.24K	0.07%	90
2020 Q4	$2.96M	Sell	47,741 -3,133	-6%	-$193K	0.1%	86
2020 Q3	$3.07M	Sell	50,874 -160	-0.3%	-$9.63K	0.12%	78
2020 Q2	$3M	Sell	51,034 -1,888	-4%	-$113K	0.11%	78
2020 Q1	$2.95M	Sell	52,922 -2,396	-4%	-$146K	0.13%	72
2019 Q4	$3.55M	Buy	55,318 +7,000	+14%	+$401K	0.1%	69
2019 Q3	$2.45M	Sell	48,318 -85	-0.2%	-$4K	0.07%	92
2019 Q2	$2.19M	Buy	48,403 +1,615	+3%	+$75.2K	0.06%	109
2019 Q1	$2.23M	Buy	+46,788	New	+$2.33M	0.06%	111

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Horizon Kinetics Asset Management's BMY Position: Q2 2026 in Review

Horizon Kinetics Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.34% in Q2 2026, selling an estimated $8.84K and leaving 44,552 shares worth $2.57M. The position accounts for 0.03% of the portfolio, ranked #105.

Horizon Kinetics Asset Management first reported a position in BMY in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.66M in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Horizon Kinetics Asset Management held 44,552 shares of Bristol-Myers Squibb worth $2.57M as of Q2 2026.
Horizon Kinetics Asset Management sold 154 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.84K.
Bristol-Myers Squibb made up 0.03% of Horizon Kinetics Asset Management's portfolio in Q2 2026, its #105 holding.
Horizon Kinetics Asset Management first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 30 quarters since.
Horizon Kinetics Asset Management's Bristol-Myers Squibb position peaked at $3.66M in Q2 2022.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.